Spyre Therapeutics
SYRE
SYRE
38 hedge funds and large institutions have $84.1M invested in Spyre Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
16
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.48M |
| 2 |
Jennison Associates
New York
|
+$1.11M |
| 3 |
Renaissance Technologies
New York
|
+$694K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$656K |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$649K |
